MC/CAR-Z2 [derivative of MC/CAR (ATCC CRL-8083)] (ATCC® CRL-8147)

Organism: Homo sapiens, human  /  Cell Type:: B lymphocyte  /  Disease: plasmacytoma; myeloma

Organism Homo sapiens, human
Cell Type B lymphocyte
Product Format frozen
Morphology lymphoblast
Culture Properties suspension
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease plasmacytoma; myeloma
Age 81 years
Gender male
Ethnicity Caucasian
Resistant to 8-azaguanine.
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Clinical Data
81 years
Resistant to 8-azaguanine.
Will die in HAT medium within 15 to 20 days.
Complete Growth Medium RPMI 1640 medium with 0.02 mg/ml 8-azaguanine, 80%; fetal bovine serum, 20%
Medium Renewal: 2 to 3 times per week
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp5 cells/ml and maintain between 4 X 10 exp5 and 5 X 10 exp6 cells/ml.
Population Doubling Time 20 to 24 hrs